Pharmacy Automation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018

This report provides an in-depth analysis and market forecast for the global pharmacy automation market for the period 2012 – 2018. The report provides details of the several pharmacy automation devices currently available in the market along with the impact of these machines on modern pharmacies in terms of efficiency, reduction in error and speed. The report also highlights the unique connection of pharmacy automation devices with a number of other markets such as the E-prescription market and its role in the growth of pharmacy automation.



Browse Report :http://www.transparencymarketresearch.com/pharmacy-automation-systems.html



The scope of the report includes competitive analysis of major market segments based on end users, technology and of different regional markets such as Europe, North America, Asia-Pacific and the rest of the world. This regional analysis concluded that most developing regions are not yet ready to accept pharmacy automation technology since affordable human skill and low currency value still provides a cheaper work force as compared to mechanization. Along with this, the cost of devices and setting them up is predicted to be another factor holding back the growth of the market.



A Porter’s Five Forces analysis provides insight into industry competition and market dynamics. End-user analysis highlights in detail the opportunities for pharmacy automation in hospitals of different sizes and in retail pharmacies. It showcases the trends in hospital investment, growth of retail pharmacies and restraints of this technology in developing regions of the world. The report also highlights PESTLE factors affecting market growth. The report’s market attractiveness analysis presents a quick overview of the emerging areas which will offer sizeable opportunities to market players.



The report also includes strategies and market entry barriers to be considered by individuals and groups who expect to venture into this arena in the coming years. Additionally, the report also includes recommendations for new entrants as well as seasoned players in the market based on current trends, and expected future market trends. To aid in tactical decision making, the report provides competitive profiling of key players, business strategies adopted by them and recent developments in the industry. This study will help suppliers, designers, manufacturers and distributors in the pharmacy automation technologies field to plan and implement their strategies in potential markets and new technologies.



Request a Sample of this Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=815


1.1 Pharmacy Automation Systems: Market Segmentation



The report segments the pharmacy automation systems market by technologies into automated medication dispensing, automated packaging and labeling, storage and retrieval systems, automated compounding systems and table-top tablet counters. According to major end users, this market is segmented into automation in hospital pharmacies and automation in retail pharmacies. The report also provides an in-depth analysis of current trends, drivers and outlook by geography in the final section.



Request for discount on this Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=815



About us:
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Electronic prescribing or E-Prescribing system (eRx) is the electronic transmission of prescription related information between prescriber, dispenser and pharmacy benefit manager. E-Prescribing system allows a physician and nurse practitioner to transmit a new prescription electronically when a medication error occurs during pharmacy operations. E-Prescribing system has a wide range of applications. It provides complete medical lists, conducts all security checks and offers complete patient historical data.



Browse Report : http://www.transparencymarketresearch.com/e-prescribing-market.html



E-Prescribing market is growing due to various government initiatives have promoted the usage of E-Prescribing system. Furthermore, improved quality of healthcare and reduced prescription errors are supporting the growth of E-Prescribing market. Additionally, advanced features of E-Prescribing system and improved healthcare infrastructure are the key driving factors for the growth of E-Prescribing market.



On the other hand, high cost of E-Prescribing system and lack of patient privacy and security impede the growth of E-Prescribing market. Lack of high-speed broadband facilities and IT professionals in rural areas are also some of the key restraints for the E-Prescribing market.



The report provides in-depth analysis and estimation of the E-Prescribing market from 2014 to 2019, considering 2013 as the base year for calculation. Additionally, data pertaining to current E-Prescribing market dynamics including market drivers, restraints, trends and recent developments have been provided in the report. The global E-Prescribing market is categorized based on product type, components, delivery mode, usage mode, end users and geography. The product type segmentation is further sub-segmented into integrated and stand-alone system. The component segment comprises software, hardware and services. The delivery mode segmentation is further sub-segmented into web-based, on-premise/licensed and cloud-based. The usage mode segmentation comprises PC-based and hand-held device. The end users segment is further sub-segmented into hospital and office-based physician.



Under geographic analysis, the report identifies and analyses the E-Prescribing market size and forecast for Europe, North America, Asia and Rest of the World (RoW). Major players operating in the E-Prescribing market are Henry Schein, Inc., Cerner Corporation, Allscripts, Emdeon and athenahealth, Inc. These key market players have been profiled based on attributes such as company overview, recent developments, growth strategies, sustainability and financial overview.



Sample Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=929



About Us :

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Computational Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018

The computational biology market is predicted to have a notable growth owing to its wide use by biotechnology and pharmaceutical companies to reduce the incidences of late stage failures of their drugs and thereby curb R&D expenditure. This market involves application of biology and information technology field for drug discovery and drug development.

Browse Report :http://www.transparencymarketresearch.com/computational-biology.html

Computational biology also assists in reducing extensive use of human in clinical trials and is therefore useful for pediatric trials, trials on pregnant women and orphan disease research. The computational biology market has witnessed significant growth in the past due to rise in late stage drug failure coupled with its ability to reduce extensive use of humans in clinical trials.

This report provides an in-depth and comprehensive analysis of the computational biology market on the basis of application, tools and by services. This report studies the global market for computational biology through the perspective of cellular modeling and disease modeling. In application segment, the report covers cellular & biological simulation and disease modeling and simulation application or CADD (Computer Aided Drug Design).

Cellular & biological simulation market has also been segmented on the basis of computational genomics, computational proteomics, pharmacogenomics and others (transcriptomics/ metabolomics). Disease modeling and simulation segment is categorized into drug discovery and drug development. The market of drug discovery is divided into target identification, target validation, lead discovery and lead optimization. Drug development market is segmented as preclinical, clinical trials and human body simulation software. The market of clinical trials is studies based on phase I, phase II and phase III trials.

The market of computational biology market, by tools is categorized into database, IT infrastructure (hardware) and analysis software and services types. The computational biology services market highlights the trend of in-house computational biology and external or contract computational biology. The report also provides various types of technological advancements taking place in each segment. All the above mentioned segments are analyzed on the basis of market size in terms of USD million and their forecasts for the period 2012 to 2018 have also been provided. The CAGR (%) for each market segment has been estimated for the forecast period 2012 to 2018, considering 2011 as the base year. In addition, this report covers participation of different organizations of the U.S. and the U.K. for the development of computational biology market.

The market is also forecasted in terms of value (USD million) for the period 2012 – 2018 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). Market sizes, forecasts and % CAGR for each region have been provided in geography segment. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the computational biology market and future opportunities are covered in the report. Moreover, a PESTLE analysis has been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has been discussed in the study. This recommendation chapter provides assistance to industry players on ways to enter this market or to establish sustainable competitive advantage.

Some of the key market players of the global computational biology market include Genedata AG, Nimbus Discovery LLC, Rhenovia Pharma SAS, Certara, Chemical Computing Group, Inc., Compugen, Ltd, Simulation Plus, Inc., Schrodinger, Leadscope, Inc., Accelrys, Entelos and Insilico Biotechnology AG. Market players are profiled in this report on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments. The competitive landscape of this industry has been covered under market share analysis by key players

Sample Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1120

About Us :

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Computational Biology Market to hit US$ 2,937.3 Million Globally in 2018: Transparency Market Research

ALBANY, New York, August 7, 2014 – In its latest market research report published recently, Transparency Market Research, a U.S.-based market intelligence firm states that the global computational biology market is estimated to be worth US$2937.3 million by 2018. The report, titled “Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokinetics, Human Simulation Software, Drug Discovery & Development) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018,” is available for sale on the company’s website.


Browse the full Report at
http://www.transparencymarketresearch.com/computational-biology.html

The report states that the global computational biology market that was valued at $ 760.2 million in the year 2011 will show a compounded annual growth rate (CAGR) of 21.3% to expand into a $2937.3 million market by 2018.



According to this report, the market for computational biology is driven by its extensive use in biotechnology and Pharma companies to decrease the frequency of the late stage drug failures in order to minimize the expenditure incurred on R&D.



Computational biology refers to using the combination of biology and computers for drug breakthroughs and their subsequent development. This entails creating simulation and modeling models for Pharmacodynamics and pharmacokinetics. Earlier, many biotech pharmaceutical firms had suffered immense financial losses owing to extreme drug failure and lack of innovative drugs. This is what led to the adoption of computational biology by many pharmaceutical companies over a period of time.



This report studies two aspects pertaining to the global computational biology market, which are disease modeling and cellular modeling. And by the use of simulation these two areas have been further examined on the basis of drug discovery and development. This market has also been categorized on the basis of parameters like software, information technology infrastructure and databases.



The report has also discussed the trends prevailing in contract and in-house computational biology. In the market for computational biology, the largest market is the market for drug discovery. The drug discovery market is very crucial because the incorporation of computational biology at this stage reduces the possibility of drug failure in the next stage which is the development phase.



Even though multinational Pharma companies are establishing their respective centers for computational biology to rev up the processes of drug discovery and development, there exists a huge market for computational biology service providers working on contract basis. The governments of many countries are investing in infrastructure development and are also introducing many academic courses to enhance the number of computational biologists in the market.



The TMR report has segmented the computational biology market on the basis of services, geography, end users and also the types. Developing countries like China and India are experiencing rapid growth in the computational biology market and will perhaps be the dominant markets in the years to come. However, currently, the largest market is North America. Prominent pharmaceutical companies like Novartis, Sanofi, Roche and Pfizer are carrying out research activities in the computational biology market, in order to generate better results of clinical trials.



This research report has given a detailed overview of the prominent pharmaceutical companies that are making use of computational biology which are Simulation Plus, Inc., Leadscope, Inc, Rhenovia Pharma SAS, Accelrys, Chemical Computing Group Inc., Entelos, Insilico Biotechnology AG, Nimbus Discovery LLC, Schrodinger, Certara, Compugen, Ltd and Genedata AG.



Sample Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1120


About Us

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact



Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Pharmacy Automation Systems Market is Expected to Reach USD 7.8 Billion by 2018: Transparency Market Research

Albany, NY, July 10, 2013 -- According to a new market report published by Transparency Market Research "Pharmacy Automation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the pharmacy automation systems market was valued at USD 4.7 billion in 2011 globally and is expected to grow to USD 7.8 billion by 2018, at a CAGR of 7.3% from 2012 to 2018.

Browse the full report: http://www.transparencymarketresearch.com/pharmacy-automation-systems.html

Automated technologies in pharmacy operations result in fewer medication errors, reduced medication cost, faster delivery time and enhanced control over pharmacy inventory. These benefits are expected to drive growth throughout the forecast period. In addition, market growth is expected to accelerate due to increasing cost pressure on healthcare providers from mounting regulatory guidelines, rising number of dosage prescriptions and reducing medical reimbursements.

In 2011, the automated medication dispensing systems segment held the largest share in the global pharmacy automation systems market accounting for 48.3% and valued at USD 2.3 billion. The segment is expected to reach USD 3.6 billion by 2018 at a CAGR of 6.7% from 2012 to 2018. Shifting trend from centralized to decentralized or hybrid hospital pharmacy in large sized hospitals to improve the medication distribution process and patient safety is accelerating the demand for these systems. However, reluctance to accept these systems is seen in emerging markets due to its high deployment cost.

The majority of revenue is generated through hospital pharmacies particularly from large sized hospitals with more than 400 beds. Low budget restrains the expenditure of small and mid-sized hospitals to invest in expensive systems. Nevertheless, increasing investment is seen from these hospitals and pharmacists in affordable technologies such as tablet counters and compounding machines. The market is foreseeing considerable expansion due to growth in retail pharmacies and drug store chains in emerging countries with the introduction of FDI in these regions.

Sample Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=815


About Us


Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.


Contact


Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com




Website: http://www.transparencymarketresearch.com/

Global market of E-Prescribing is expected to reach USD 887.8 million in 2019

According to a new market report published by Transparency Market Research “Global E-Prescribing Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019", the market was valued at USD 11.16 billion in 2012, and is expected to reach USD 15.90 billion by 2019, growing at a CAGR of 5.2% from 2013 to 2019. Lack of adequate power infrastructure and increasing demand for reliable electricity delivery are the major driving forces of this market.

Browse the full E-Prescribing Market Report at : http://www.transparencymarketresearch.com/e-prescribing-market.html

The global E-Prescribing market is witnessing a significant growth led by various government programs to implement E-Prescribing systems in order to improve quality of healthcare and reduce medication errors. The E-Prescribing system is used in various applications including preparation of complete medication list, data security checks, complete information of formulary and patient historical data. These advanced features of E-Prescribing are some of the key driving factors for the E-Prescribing market. Additionally, improved healthcare infrastructure has increased the demand for E-Prescribing system. Moreover, implementation of electronic healthcare records with E-Prescribing system holds immense potential for the growth of E-Prescribing market. E-Prescribing market is expected to grow a CAGR of about 23.5% during 2013-2019.

On the other hand, high cost of E-Prescribing system and lack of patient privacy and security impede the growth of E-Prescribing market. Moreover, lack of high-speed broadband facilities and IT professionals in rural areas are also some of the key restraints for the E-Prescribing market.

Europe is the largest market for E-Prescribing system. Many eHealth projects in Europe are playing a vital role in the adoption of E-Prescribing system such as European Patient Smart Open Services (epSOS) and Schleswig-Holstein Health Initiative.

However, North America is the fastest growing region in the E-Prescribing market. Increased adoption of E-Prescribing system and improved healthcare infrastructure are major drivers for E-Prescribing market in North America. Moreover, several government initiatives are also promoting the usage of E-Prescribing system such as Health Information Technology for Economic and Clinical Health (HITECH) Act and National Council for Prescription Drugs Program.

In Asia, usage of E-Prescribing system is increasing due to medical infrastructure development and government initiative programs. Growing medical infrastructure has led to improvement in primary healthcare services, village clinics and urban healthcare centers through the adoption of healthcare IT technologies.
Henry Schein, Inc. and Cerner Corporation are the leading player in the global E-Prescribing market. Other major players of E-Prescribing market include athenahealth, Inc., DrFirst, eClinicalWorks, HealthFusion, Inc., and Practice Fusion, Inc.

The global market of E-Prescribing is segmented as follows:
E-Prescribing Market, By Product Type


Integrated system
Stand-alone system
E-Prescribing Market, By Component

Software
Hardware
Services
E-Prescribing Market, By Delivery Mode
Web-based
On-premise/licensed
Cloud-based

E-Prescribing Market, By Usage Mode
Hand-held device
PC-based

E-Prescribing Market, By End User
Hospital
Office-based physician

E-Prescribing Market, by Geography
Europe
Germany
The U.K.
France
The Netherlands
North America
The U.S.
Canada
Asia
Japan
China
Rest of the World (RoW)


About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.


Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Computational Biology Market to hit US$ 2,937.3 Million Globally in 2018: Transparency Market Research

ALBANY, New York, August 7, 2014 – In its latest market research report published recently, Transparency Market Research, a U.S.-based market intelligence firm states that the global computational biology market is estimated to be worth US$2937.3 million by 2018. The report, titled “Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokinetics, Human Simulation Software, Drug Discovery & Development) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018,” is available for sale on the company’s website.



Browse the full Report at
http://www.transparencymarketresearch.com/computational-biology.html

The report states that the global computational biology market that was valued at $ 760.2 million in the year 2011 will show a compounded annual growth rate (CAGR) of 21.3% to expand into a $2937.3 million market by 2018.According to this report, the market for computational biology is driven by its extensive use in biotechnology and Pharma companies to decrease the frequency of the late stage drug failures in order to minimize the expenditure incurred on R&D.



Computational biology refers to using the combination of biology and computers for drug breakthroughs and their subsequent development. This entails creating simulation and modeling models for Pharmacodynamics and pharmacokinetics. Earlier, many biotech pharmaceutical firms had suffered immense financial losses owing to extreme drug failure and lack of innovative drugs. This is what led to the adoption of computational biology by many pharmaceutical companies over a period of time.



This report studies two aspects pertaining to the global computational biology market, which are disease modeling and cellular modeling. And by the use of simulation these two areas have been further examined on the basis of drug discovery and development. This market has also been categorized on the basis of parameters like software, information technology infrastructure and databases.



The report has also discussed the trends prevailing in contract and in-house computational biology. In the market for computational biology, the largest market is the market for drug discovery. The drug discovery market is very crucial because the incorporation of computational biology at this stage reduces the possibility of drug failure in the next stage which is the development phase.



Even though multinational Pharma companies are establishing their respective centers for computational biology to rev up the processes of drug discovery and development, there exists a huge market for computational biology service providers working on contract basis. The governments of many countries are investing in infrastructure development and are also introducing many academic courses to enhance the number of computational biologists in the market.



The TMR report has segmented the computational biology market on the basis of services, geography, end users and also the types. Developing countries like China and India are experiencing rapid growth in the computational biology market and will perhaps be the dominant markets in the years to come. However, currently, the largest market is North America. Prominent pharmaceutical companies like Novartis, Sanofi, Roche and Pfizer are carrying out research activities in the computational biology market, in order to generate better results of clinical trials.



This research report has given a detailed overview of the prominent pharmaceutical companies that are making use of computational biology which are Simulation Plus, Inc., Leadscope, Inc, Rhenovia Pharma SAS, Accelrys, Chemical Computing Group Inc., Entelos, Insilico Biotechnology AG, Nimbus Discovery LLC, Schrodinger, Certara, Compugen, Ltd and Genedata AG.



About Us

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com




Website: http://www.transparencymarketresearch.com/

Global Pharmacy Automation Systems Market is Expected to Reach USD 7.8 Billion by 2018: Transparency Market Research

Albany, NY, July 10, 2013 -- According to a new market report published by Transparency Market Research "Pharmacy Automation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the pharmacy automation systems market was valued at USD 4.7 billion in 2011 globally and is expected to grow to USD 7.8 billion by 2018, at a CAGR of 7.3% from 2012 to 2018.

Browse the full report: http://www.transparencymarketresearch.com/pharmacy-automation-systems.html.

Automated technologies in pharmacy operations result in fewer medication errors, reduced medication cost, faster delivery time and enhanced control over pharmacy inventory. These benefits are expected to drive growth throughout the forecast period. In addition, market growth is expected to accelerate due to increasing cost pressure on healthcare providers from mounting regulatory guidelines, rising number of dosage prescriptions and reducing medical reimbursements.

In 2011, the automated medication dispensing systems segment held the largest share in the global pharmacy automation systems market accounting for 48.3% and valued at USD 2.3 billion. The segment is expected to reach USD 3.6 billion by 2018 at a CAGR of 6.7% from 2012 to 2018. Shifting trend from centralized to decentralized or hybrid hospital pharmacy in large sized hospitals to improve the medication distribution process and patient safety is accelerating the demand for these systems. However, reluctance to accept these systems is seen in emerging markets due to its high deployment cost.

The majority of revenue is generated through hospital pharmacies particularly from large sized hospitals with more than 400 beds. Low budget restrains the expenditure of small and mid-sized hospitals to invest in expensive systems. Nevertheless, increasing investment is seen from these hospitals and pharmacists in affordable technologies such as tablet counters and compounding machines. The market is foreseeing considerable expansion due to growth in retail pharmacies and drug store chains in emerging countries with the introduction of FDI in these regions.

Sample Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=815



About Us



Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.




Contact


Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com



Website: http://www.transparencymarketresearch.com/